LCM
CBAY

Lynx1 Capital Management’s Cymabay Therapeutics CBAY Stock Holding History

Lynx1 Capital Management’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-994,161
Closed -$14.8M – 18
2023
Q3 		$14.8M Sell
994,161
-210,889
-18% -$2.8M 9.8% 4
2023
Q2 		$13.2M Sell
1,205,050
-164,877
-12% -$1.54M 8.65% 4
2023
Q1 		$11.9M Sell
1,369,927
-283,568
-17% -$2.27M 9.96% 5
2022
Q4 		$10.4M Sell
1,653,495
-672,338
-29% -$2.56M 8.97% 5
2022
Q3 		$8.14M Sell
2,325,833
-263,846
-10% -$948K 7.34% 5
2022
Q2 		$7.64M Buy
2,589,679
+1,201,174
+87% +$2.87M 6.51% 5
2022
Q1 		$4.32M Buy
1,388,505
+163,537
+13% +$515K 4.01% 8
2021
Q4 		$4.14M Buy
+1,224,968
New +$4.65M 3.61% 8

Other funds holding CBAY

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return